Annual CMHC: Honoring the life and legacy of CMHC co-chair George L. Bakris, MD
Click Here to Manage Email Alerts
Key takeaways:
- The annual Cardiometabolic Health Congress will be held in October in Boston.
- Attendees will hear the latest on trending topics in cardiorenal and cardiometabolic health.
For nearly 2 decades, George L. Bakris, MD, was a pillar of the Cardiometabolic Health Congress, sharing his expertise, passion and unwavering dedication to advancing cardiometabolic health.
With his support, CMHC has championed a vision of a brighter future for clinicians, patients and the entire health care sector, according to a CMHC press release.
In October, attendees will gather for the largest and most innovative cardiometabolic event, honoring Bakris’ profound impact on our community.
Taking place Oct. 17 to 19 at the Boston Park Plaza, this is a must-attend event for health care professionals across all specialties and sectors.
This year’s congress is themed Decoding the Constellation of Cardiometabolic Health and Risk Factors and will tackle the growing health threat posed by cardiometabolic diseases, affecting 47 million people in the United States. The focus will be on the intricate interplay between cardiorenal and metabolic conditions, such as type 2 diabetes, cardiovascular disease and chronic kidney disease, driven by lifestyle and health factors. Attendees will gain valuable clinical insights and explore cutting-edge therapies aimed at improving overall health outcomes.
“Dr. Bakris was ahead of his time, what we would call prescient in that, although he was a nephrologist, he saw the link between the kidney, high blood pressure, diabetes and the overall cardiometabolic condition. When I heard of his passing, I felt quite sad. But all of us can also smile remembering this great person, George Bakris,” Keith C. Ferdinand, MD, FACC, FAHA, FASPC, FNLA, the Gerald S. Berenson Endowed Chair in Preventive Cardiology and professor of medicine at Tulane University School of Medicine and longtime CMHC faculty member, said in the release.
The George L. Bakris Scholarship Program is now available to students, fellows and clinicians-in-training with an interest in cardiometabolic medicine. This scholarship honors the legacy of Bakris, who was a passionate advocate for education in cardiorenal and metabolic medicine. To apply, click here.
During the event, attendees will connect with peers while experiencing a full range of educational sessions and unique activities.
Timely, practical, leading-edge topics include:
- Albuminuria Change as a Marker for CKD Progression – Ajay K. Singh, MBBS, FRCP, MBA;
- Advances in Obesity Pharmacotherapy – Louis J. Aronne, MD;
- Expert Perspectives on Initiating and Maintaining Insulin Therapy in Type 2 Diabetes Patients – Jay H. Shubrook, DO, FAAFP, FACOFP;
- CGM in People without Diabetes and CVD Risk – Grazia Aleppo, MD, FACE, FACP and
- How to Improve Cardiovascular Outcomes in Women – Martha Gulati, MD, MS, FACC, FAHA, FASPC, FESC.
CME-supported satellites and sessions include:
- Primetime CME Symposium: Integrated Approach to Cardiorenal Management: Maximizing SGLT2 Inhibitor Benefits and Early Detection of HF and CKD – supported by an educational grant from BI-Lilly. Chair: Erin D. Michos, MD. Presenters: Chiadi Ndumele, MD, and Pam R. Taub, MD;
- Primetime CME Symposium: Addressing the Cardiometabolic Risk Continuum in MASH: What Clinicians Need to Know – supported by an educational grant from Novo Nordisk. Co-presenters: Diana Barb, MD, and Mitchell L. Shiffman, MD;
- CME-supported session: LDL-lowering Therapy Beyond Statin – supported by an educational grant from Esperion Therapeutics. Presenter: Pamela B. Morris, MD; and
- CME-supported session: New and Emerging Agents for Dyslipidemia and Hypertriglyceridemia – supported by an educational grant from Arrowhead Pharmaceuticals. Presenter: Michael D. Shapiro, DO.
Cardiology expert Peter Libby, MD, a cardiovascular medicine specialist at Brigham and Women’s Hospital and the Mallinckrodt Professor of Medicine at Harvard Medicine School, will keynote the 19th annual CMHC. Libby will provide an update on his groundbreaking research on inflammation and atherosclerosis, offering practical clinical approaches.
Additionally, there will be happy hour and giveaways, featuring live entertainment and opportunities to forge lasting connections, according to the release
“Dr. Bakris refused to slow down or give up after he was diagnosed. He fought really hard and on top of it he continued to work as if nothing had happened. Above all, he was a very warm person. Always gracious with his time and his advice on what to do, what not to do, especially when we were serving on various steering committees. You will be missed greatly by all of us,” Rajiv Agarwal, MD, MS, professor of medicine at Indiana University School of Medicine and CMHC faculty member, said in the release.
CMHC invites those interested in cardiorenal medicine and the latest advancements in understanding, treating and preventing cardiorenal metabolic-related risk factors and diseases to join in exploring innovative health care solutions and driving progress in the field.
Healio is an official media partner of CMHC. The Healio team will provide live coverage from the meeting, including reports on the sessions above and more.
For more information:
To register for the 19th annual CMHC, visit www.cardiometabolichealth.org/19th-annual-cmhc/.
Collapse
Click Here to Manage Email Alerts